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mothers2mothers’ (m2m) Mentor Mother Model improves maternal and infant health outcomes and psychosocial 
wellbeing when compared to health facilities without m2m and achieves significant savings by preventing paediatric 
HIV infections, thereby reducing HIV treatment costs. All findings presented in this summary are statistically 
significant, and include:
The m2m Mentor Mother Model has a high return on investment:
Retention-in-care of HIV-positive women 12 months 
after being initiated on triple antiretroviral drugs (ART)
Uptake of early infant diagnosis test for HIV 6-8 weeks after birth 
Reduced mother-to-child HIV transmission rates 18 months 
after birth
Greater psychosocial wellbeing among women supported by Mentor Mothers:  
coping self-efficacy
HIV disclosure and safer sex self-efficacy
no symptoms of depression
coping behaviour
Initiation of HIV-positive infants on ART
If m2m’s programme were to be implemented on a national level in Uganda:
$1
$511,724
=
=
spent on m2m’s 
Mentor Mother Model 
million in savings on 
treatment costs over 
lifetime of HIV-negative 
infants
in savings of averted 
treatment costs
paediatric HIV 
infections would be 
prevented each year
$11.40 
71.5%
90.9% 
6.8%
86.6%
71.7%
83.3%
69.4%
60.9%
45.8%
63.6% 
8.7%
64.5%
50.7%
78.1%
56.9%
27.8%
vs
vs
vs
vs
vs
vs
vs
vs
m2m-supported 
health facilities
health facilities with 
no m2m presence
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Introduction
mothers2mothers’ Mentor Mother programme has operated in Uganda since 2010 under the Strengthening TB 
and HIV & AIDS Response in East Central Uganda (STAR-EC) programme. STAR-EC is a six-year initiative funded by 
the United States Agency for International Development (USAID) that covers nine districts in East Central Uganda 
and serves a population of approximately 3.1 million people (9% of Uganda’s total population). m2m operates its 
programme in partnership with JSI Research & Training Institute Inc, which has been implementing HIV & AIDS and 
TB-related activities in East Central Uganda since March 2009.
In 2012, mother-to-child transmission of HIV was the second most common mode of HIV transmission in Uganda.  
It accounted for up to 18% of all new infections, and was virtually the only way that young children (under two years 
of age) acquired HIV. Uganda adopted Option B+ in September 2012, offering all HIV-positive pregnant women the 
opportunity to take triple antiretroviral drugs (ART) for the rest of their lives, with significant benefits for their own 
health, the health of their unborn babies, and the health of their partners. To fully recognise the promise of Option 
B+, substantially greater efforts are needed to link pregnant women and children to HIV treatment and care, and 
minimise the number of pregnant women, mothers, and their infants who drop out of care at some point during 
their treatment.
m2m trains, employs, and empowers mothers living with HIV to eliminate the transmission of HIV from mothers 
to babies and improve the health of women, their partners, and families. Working alongside doctors and nurses in 
understaffed health centres as members of the healthcare team, these “Mentor Mothers,” as they are called, provide 
essential health education and psychosocial support to other HIV-positive pregnant women and new mothers.  
Psychosocial support addresses ongoing emotional, psychological, social, and cultural concerns, helping HIV-
positive pregnant women, new mothers, and their families cope more effectively with each stage of the infection 
and enhancing their quality of life.
This external evaluation examines whether the core component of m2m’s Mentor Mother Model–peer education 
and psychosocial support services—improves the uptake of PMTCT services, as well as the health and wellbeing 
of mothers and their infants. It also investigates the cost-benefit of scaling up the Mentor Mother Model nationally 
in Uganda. To determine this, the study examines the differences in mother and infant uptake of PMTCT services 
and health outcomes, as well as women’s psychosocial wellbeing at m2m-supported health facilities compared to 
similar facilities with no m2m presence (the control sites).
The study was conducted across 62 health facilities divided into two groups: 31 intervention sites (with an m2m 
presence) and 31 control sites (without m2m presence). Approximately 1,150 mother-baby pair records of clients 
who received PMTCT services between January 2011 and March 2014 were reviewed in each group. Additionally, 
approximately 400 PMTCT clients in each group who received PMTCT services between June 2012 and March 
2014 participated in a survey measuring their psychosocial wellbeing. 
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Maternal and Infant Health Outcomes and Impact
The evaluation finds that the m2m Mentor Mother Model, as implemented for the USAID-funded STAR-EC 
programme in Uganda, has a positive impact on maternal and infant health outcomes and mother-to-child HIV 
transmission rates, compared to control sites that do not provide peer education and psychosocial support services. 
Significant improvements among m2m clients are observed in 13 of 14 PMTCT outcome indicators, and in two out of 
three infant health impact indicators. 
Women attending an m2m-supported health facility are more likely to take up PMTCT services, particularly those 
associated with linking them to or retaining them in care, including:
•	 HIV testing for infants at six weeks after birth, at six weeks after cessation of breast feeding, and at 18 months  
 after birth
•	 Admission of HIV-positive babies into paediatric ART services
• Provision of antiretroviral (ARV) drugs to HIV-exposed babies at birth
• Retention of pregnant women on ART
The evaluation also finds that exposure to m2m services significantly reduces the number of HIV-positive mothers 
who drop out of treatment and results in improved behaviours that have been linked to a reduction of MTCT such as 
attending at least four antenatal visits, delivery under the care of a skilled health professional, use of modern family 
planning methods, and disclosure of HIV status to sexual partners.
Maternal PMTCT Outcomes:  
The percentage of women in m2m-supported health facilities and control health facilities who...
m2m facilities Control group
Have four or more antenatal 
appointments during pregnancy
Give birth in the presence of 
skilled health professional
Stay on ART for 12 months
after they initiated treatment
Disclose their HIV status to partner
Exclusively breastfeed baby
for first six months
Drop out of treatment 12 months 
after being initiated on ART
Use a family planning method
appropriate for their needs
49.3%
82.1%
87.1%
90.1%
90.9%
55.9%
75.8%
63.6%
63.2%
38.0%
5.9%
31.3%
68.9%
39.7%
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Infant PMTCT Outcomes:  
The percentage of infants with mothers attending m2m-supported health facilities and control health 
facilities who...
m2m facilities Control group
Receive Nevirapine syrup at birth
Receive an HIV test six weeks 
after cessation of breastfeeding
Inintiate (if HIV-infected) 
on paediatric ART
Receive a PCR test six weeks after 
birth to determine HIV status
Receive an HIV test 18 months 
after delivery as final confirmation 
of HIV status
86.0%
71.5%
60.5%
60.2%
60.9%
18.1%
31.4%
27.8%
45.8%
59.0%
Mother-to-Child Transmission Rates: 
m2m’s Mentor Mother Model is significantly associated with a reduction in mother-to-child-
transmission rates of HIV at both six weeks and 18 months after birth. The percentage of infants whose 
mothers are in m2m-supported health facilities and control health facilities who test HIV-positive:
m2m facilities Control group
HIV infection at 6 weeks after birth
HIV infection at 18 months 
after births
6.8%
8.7%
5.4%
3.8%
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Psychosocial Wellbeing Outcomes
Through the education and psychosocial support that Mentor Mothers provide their clients and that clients provide 
one another in m2m support groups, women develop key attitudes, beliefs, and skills necessary to overcome 
negative social norms often prevalent within many families and communities. Self-efficacy (the belief in one’s ability 
to succeed in a particular situation) is at the centre of this process of empowerment. Through improved self-
efficacy that develops from engaging with a Mentor Mother, women are better able to overcome social pressures 
that can prevent them from adopting healthier behaviours and accessing critical health services.
The evaluation finds that HIV-positive mothers who access antenatal services at m2m-supported health facilities 
have better overall psychosocial wellbeing compared to their counterparts who access antenatal services at control 
health facilities with no peer education and psychosocial support. Significant improvements among m2m clients 
are observed in 11 of 12 psychosocial wellbeing outcome indicators. 
The percentage of women who demonstrate greater psychosocial wellbeing on selected 
outcomes include: 
m2m facilities Control group
Experience of social support
Coping behaviour
No symptoms of depression 
Coping self-efficacy
HIV disclosure and safer sex 
self-efficacy
Good communication with 
health worker
Good communication with partner
80.1%
86.6%
69.4%
83.3%
50.7%
56.9%
78.1%
72.2%
58.3%
95.2%
86.0%
64.5%
71.7%
71.7%
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Cost-Benefit of Scaling Up m2m’s Mentor Mother Programme Nationally
A cost-benefit analysis was conducted as part of the external evaluation, using the impact results discussed above. 
A cost-benefit analysis offers more robust results than a cost-effectiveness analysis, since it can compare financial 
investment to a monetised value of the outcome or impact of an intervention. 
This analysis demonstrates that investing in the m2m Mentor Mother programme as an intervention for preventing 
the transmission of HIV from mother-to-child has a very high return on investment given the great benefits, 
compared to the cost required to implement it. The study finds that for every $1 spent on the m2m programme, 
there is a cost savings of $11.40 associated with averted treatment costs.
The analysis estimates that the cost of scaling up of the m2m Mentor Mother programme in public and private 
not-for-profit health facilities in Uganda is approximately $4.5 million annually. Assuming that the same magnitude 
of impact would be achieved across the country as measured in the sampled health facilities, scaling up of the 
m2m intervention to the whole country would prevent approximately 1,724 infant infections in one year. If not 
prevented, the infected individuals would be required to take ART from birth for the rest of their lives. The estimated 
cost savings associated with the prevention of 1,724 infant infections is approximately $51 million over the lifetime 
of infants born HIV-negative which can be attributed to m2m prevention efforts.
Conclusion
Based on this evidence, the external evaluators recommend that Uganda should consider scaling up the m2m 
Mentor Mother Model as part of the standard of care for delivering psychosocial support to all PMTCT clients 
in Uganda.
A number of evaluations have been conducted on the effectiveness of psychosocial support on health outcomes 
and particularly on PMTCT outcomes. However, the evaluation of the Mentor Mother Model as implemented under 
the STAR-EC Program in Uganda is unusual in its scope, in that it comprehensively addresses the impact of m2m’s 
intervention on psychosocial wellbeing, PMTCT outcomes, and mother-to-child transmission rates. Furthermore, 
very few evaluations go as far as conducting the highest form of economic evaluation—a cost-benefit analysis. The 
consistency of positive results found across indicators measured in this evaluation is remarkable, and demonstrates 
that the standard of care provided by m2m’s Mentor Mother Model achieves its objectives.
